Literature DB >> 31167575

Fibrinogen-like protein 2: a potential molecular target for glioblastoma treatment.

Rajan Patel1, Jeffrey I Traylor1, Khatri Latha1, Amy B Heimberger1, Shulin Li2, Ganesh Rao1.   

Abstract

Entities:  

Keywords:  FGL2; glioblastoma multiforme; low grade glioma; progression

Mesh：

Substances：

Year:  2019        PMID： 31167575      PMCID： PMC6635074          DOI： 10.1080/14728222.2019.1628220

Source DB:  PubMed          Journal:  Expert Opin Ther Targets        ISSN： 1472-8222            Impact factor:   6.902


× No keyword cloud information.
  15 in total

Review 1.  Immunotherapy coming of age: what will it take to make it standard of care for glioblastoma?

Authors:  Amy B Heimberger; John H Sampson
Journal:  Neuro Oncol       Date:  2010-12-10       Impact factor: 12.300

2.  Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity.

Authors:  Miranda L Broz; Mikhail Binnewies; Bijan Boldajipour; Amanda E Nelson; Joshua L Pollack; David J Erle; Andrea Barczak; Michael D Rosenblum; Adil Daud; Diane L Barber; Sebastian Amigorena; Laura J Van't Veer; Anne I Sperling; Denise M Wolf; Matthew F Krummel
Journal:  Cancer Cell       Date:  2014-10-16       Impact factor: 31.743

3.  FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.

Authors:  Jun Yan; Ling-Yuan Kong; Jiemiao Hu; Konrad Gabrusiewicz; Denada Dibra; Xueqing Xia; Amy B Heimberger; Shulin Li
Journal:  J Natl Cancer Inst       Date:  2015-05-13       Impact factor: 13.506

4.  Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells.

Authors:  Camie W Y Chan; Lyndsey S Kay; Rachel G Khadaroo; Matthew W C Chan; Sophia Lakatoo; Kevin J Young; Li Zhang; Reginald M Gorczynski; Mark Cattral; Ori Rotstein; Gary A Levy
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

5.  The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.

Authors:  S Farzana Hussain; David Yang; Dima Suki; Kenneth Aldape; Elizabeth Grimm; Amy B Heimberger
Journal:  Neuro Oncol       Date:  2006-06-14       Impact factor: 12.300

Review 6.  Overview of cellular immunotherapy for patients with glioblastoma.

Authors:  Elodie Vauleon; Tony Avril; Brigitte Collet; Jean Mosser; Véronique Quillien
Journal:  Clin Dev Immunol       Date:  2010-10-04

Review 7.  Prospects of immune checkpoint modulators in the treatment of glioblastoma.

Authors:  Matthias Preusser; Michael Lim; David A Hafler; David A Reardon; John H Sampson
Journal:  Nat Rev Neurol       Date:  2015-08-11       Impact factor: 42.937

8.  Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143.

Authors:  Antonio Omuro; Gordana Vlahovic; Michael Lim; Solmaz Sahebjam; Joachim Baehring; Timothy Cloughesy; Alfredo Voloschin; Shakti H Ramkissoon; Keith L Ligon; Robert Latek; Ricardo Zwirtes; Lewis Strauss; Prashni Paliwal; Christopher T Harbison; David A Reardon; John H Sampson
Journal:  Neuro Oncol       Date:  2018-04-09       Impact factor: 12.300

Review 9.  Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment.

Authors:  Christopher Jackson; Jacob Ruzevick; Jillian Phallen; Zineb Belcaid; Michael Lim
Journal:  Clin Dev Immunol       Date:  2011-12-10

10.  Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane.

Authors:  Ravi Kumar; Tristan de Mooij; Timothy E Peterson; Tatiana Kaptzan; Aaron J Johnson; David J Daniels; Ian F Parney
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240
View more
  2 in total

1.  Tumor-associated macrophage polarization promotes the progression of esophageal carcinoma.

Authors:  Xin Yuan; Ya Li; An Zhi Zhang; Chen Hao Jiang; Fan Ping Li; Yu Fang Xie; Jiang Fen Li; Wei Hua Liang; Hai Jun Zhang; Chun Xia Liu; Li Juan Pang; Xi Hua Shen; Feng Li; Jian Ming Hu
Journal:  Aging (Albany NY)       Date:  2020-12-15       Impact factor: 5.682

Review 2.  The role of Fibrinogen-like proteins in Cancer.

Authors:  Jing Yu; Jing Li; Jing Shen; Fukuan Du; Xu Wu; Mingxing Li; Yu Chen; Chi Hin Cho; Xiaobing Li; Zhangang Xiao; Yueshui Zhao
Journal:  Int J Biol Sci       Date:  2021-03-08       Impact factor: 6.580
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.